Insider Trades32 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Sell | TBRG | Vita Macintyre | Controller | 187 | $14.07 | $393.6M | -1.02% | +89.05% | $2.6K | -9.52% | — | Buy Now |
| Mar 13, 2026 | Sell | TBRG | Vita Macintyre | Controller | 125 | $17.31 | $393.6M | -1.02% | +89.05% | $2.2K | -5.98% | — | Buy Now |
| Mar 13, 2026 | Sell | TBRG | Merideth Wilson | Financial Health GM | 604 | $17.31 | $393.6M | -1.02% | +89.05% | $10.5K | -8.12% | — | Buy Now |
| Mar 13, 2026 | Sell | TBRG | Kevin Plessner | General Counsel | 1,165 | $17.51 | $393.6M | -1.02% | +89.05% | $20.4K | -4.48% | — | Buy Now |
| Mar 13, 2026 | Sell | TBRG | David Harse | General Manager Patient Care | 1,669 | $17.49 | $393.6M | -1.02% | +89.05% | $29.2K | -4.80% | — | Buy Now |
| Mar 13, 2026 | Sell | TBRG | Vinay Bassi | Chief Financial Officer | 5,723 | $17.50 | $393.6M | -1.02% | +89.05% | $100.2K | -6.71% | — | Buy Now |
| Mar 13, 2026 | Sell | TBRG | Christopher L Fowler | President and CEO | 8,122 | $17.51 | $393.6M | -1.02% | +89.05% | $142.2K | -3.27% | — | Buy Now |
| Mar 9, 2026 | Sell | TBRG | Kevin Plessner | General Counsel | 280 | $18.47 | $393.6M | -1.02% | +89.05% | $5.2K | -2.08% | — | Buy Now |
| Mar 9, 2026 | Sell | TBRG | David Harse | General Manager Patient Care | 377 | $18.47 | $393.6M | -1.02% | +89.05% | $7.0K | -2.09% | — | Buy Now |
| Mar 9, 2026 | Sell | TBRG | Christopher L Fowler | President and CEO | 2,093 | $18.47 | $393.6M | -1.02% | +89.05% | $38.7K | -1.64% | — | Buy Now |
| Nov 11, 2025 | Buy | TBRG | Michael Daughton | Chief Business Officer | 50,000 | $19.98 | $393.6M | -1.02% | +89.05% | $999.2K | +35.44% | — | Buy Now |
| May 20, 2025 | Sell | TBRG | Vita Macintyre | Controller | 335 | $24.94 | $393.6M | -1.02% | +89.05% | $8.4K | -13.81% | — | Buy Now |
| May 16, 2025 | Sell | TBRG | Christopher L Fowler | President and CEO | 6,000 | $25.05 | $393.6M | -1.02% | +89.05% | $150.3K | -4.38% | — | Buy Now |
| Mar 27, 2025 | Sell | TBRG | Vita Macintyre | Controller | 188 | $28.53 | $393.6M | -1.02% | +89.05% | $5.4K | -7.19% | — | Buy Now |
| Mar 17, 2025 | Sell | TBRG | Kevin Plessner | General Counsel | 798 | $28.10 | $393.6M | -1.02% | +89.05% | $22.4K | -5.60% | — | Buy Now |
| Mar 17, 2025 | Sell | TBRG | David Harse | General Manager Patient Care | 1,098 | $28.10 | $393.6M | -1.02% | +89.05% | $30.9K | -5.25% | — | Buy Now |
| Mar 17, 2025 | Sell | TBRG | Dawn M Severance | Chief Sales Officer | 1,122 | $28.10 | $393.6M | -1.02% | +89.05% | $31.5K | -3.54% | — | Buy Now |
| Mar 17, 2025 | Sell | TBRG | Vinay Bassi | Chief Financial Officer | 3,965 | $28.10 | $393.6M | -1.02% | +89.05% | $111.4K | -8.35% | — | Buy Now |
| Mar 17, 2025 | Sell | TBRG | Christopher L Fowler | President and CEO | 5,849 | $28.10 | $393.6M | -1.02% | +89.05% | $164.4K | -4.09% | — | Buy Now |
| Mar 14, 2025 | Sell | TBRG | David Harse | General Manager Patient Care | 1,744 | $27.40 | $393.6M | -1.02% | +89.05% | $47.8K | -8.81% | — | Buy Now |
| Mar 14, 2025 | Sell | TBRG | Christopher L Fowler | President and CEO | 5,100 | $27.02 | $393.6M | -1.02% | +89.05% | $137.8K | -3.45% | — | Buy Now |
| Mar 7, 2025 | Sell | TBRG | Kevin Plessner | General Counsel | 517 | $28.31 | $393.6M | -1.02% | +89.05% | $14.6K | -2.21% | — | Buy Now |
| Mar 7, 2025 | Sell | TBRG | Dawn M Severance | Chief Sales Officer | 714 | $28.30 | $393.6M | -1.02% | +89.05% | $20.2K | -1.31% | — | Buy Now |
| Mar 7, 2025 | Sell | TBRG | Christopher L Fowler | President and CEO | 2,883 | $28.30 | $393.6M | -1.02% | +89.05% | $81.6K | -1.13% | — | Buy Now |
| Jul 1, 2024 | Sell | TBRG | Christopher L Fowler | President and CEO | 3,786 | $18.34 | $393.6M | -1.02% | +89.05% | $69.4K | -1.45% | — | Buy Now |
| Mar 7, 2024 | Sell | TBRG | Lance Park | VP Finance & Controller | 339 | $8.07 | $393.6M | -1.02% | +89.05% | $2.7K | -9.91% | — | Buy Now |
| Mar 7, 2024 | Sell | TBRG | Kevin Plessner | General Counsel | 734 | $8.34 | $393.6M | -1.02% | +89.05% | $6.1K | -7.30% | — | Buy Now |
| Mar 7, 2024 | Sell | TBRG | Dawn M Severance | SVP of TruBridge, Sales | 1,308 | $8.38 | $393.6M | -1.02% | +89.05% | $11.0K | -4.53% | — | Buy Now |
| Mar 7, 2024 | Sell | TBRG | Wes Cronkite | Chief Technology & Innovation | 1,456 | $8.07 | $393.6M | -1.02% | +89.05% | $11.7K | -6.60% | — | Buy Now |
| Mar 7, 2024 | Sell | TBRG | David A Dye | Chief Operating Officer | 3,019 | $8.33 | $393.6M | -1.02% | +89.05% | $25.2K | -2.23% | — | Buy Now |
| Mar 7, 2024 | Sell | TBRG | Christopher L Fowler | President and CEO | 3,733 | $8.28 | $393.6M | -1.02% | +89.05% | $30.9K | -2.31% | — | Buy Now |
| Nov 14, 2023 | Buy | TBRG | Christopher L Fowler | President and CEO | 16 | $11.16 | $393.6M | -1.02% | +89.05% | $178.63 | +69.57% | — | Buy Now |